Trial · NCT03880474
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | MVA-NP+M1 Group | 115 | 1,077 | 122 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Saline Placebo Group | 119 | 1,075 | 127 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | MVA-NP+M1 Group | 89 | 1,077 | 97 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | Saline Placebo Group | 93 | 1,075 | 102 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | MVA-NP+M1 Group | 90 | 1,077 | 95 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | Saline Placebo Group | 84 | 1,075 | 93 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | MVA-NP+M1 Group | 73 | 1,077 | 76 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Saline Placebo Group | 86 | 1,075 | 91 |
| other | Sneezing | Respiratory, thoracic and mediastinal disorders | MVA-NP+M1 Group | 25 | 1,077 | 28 |
| other | Sneezing | Respiratory, thoracic and mediastinal disorders | Saline Placebo Group | 12 | 1,075 | 13 |
| other | Headache | Nervous system disorders | MVA-NP+M1 Group | 145 | 1,077 | 170 |
| other | Headache | Nervous system disorders | Saline Placebo Group | 122 | 1,075 | 135 |
| other | Dizziness | Nervous system disorders | MVA-NP+M1 Group | 12 | 1,077 | 12 |
| other | Dizziness | Nervous system disorders | Saline Placebo Group | 0 | 1,075 | 0 |
| other | Migraine | Nervous system disorders | MVA-NP+M1 Group | 0 | 1,077 | 0 |
| other | Migraine | Nervous system disorders | Saline Placebo Group | 12 | 1,075 | 15 |
| other | Injection site pain | General disorders | MVA-NP+M1 Group | 73 | 1,077 | 74 |
| other | Injection site pain | General disorders | Saline Placebo Group | 0 | 1,075 | 0 |
| other | Fatigue | General disorders | MVA-NP+M1 Group | 43 | 1,077 | 46 |
| other | Fatigue | General disorders | Saline Placebo Group | 24 | 1,075 | 25 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03880474/events